Mohammad Azab
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 18
- Histone Deacetylase Inhibitors Research 7
- RNA modifications and cancer 6
- Hematology 11
- Acute Myeloid Leukemia Research 11
- Co-authors
- Karem H. Alzoubi (11 shared papers)Omar F. Khabour (11 shared papers)Pietro Taverna (19 shared papers)Thomas Eissenberg (4 shared papers)May F. Sadiq (2 shared papers)Gavin Choy (12 shared papers)Aram Oganesian (7 shared papers)Brian A. Primack (2 shared papers)
- Journals
- Cancer Research (6 papers)Journal of Clinical Oncology (6 papers)Blood (5 papers)Clinical Cancer Research (3 papers)Nicotine & Tobacco Research (3 papers)
- Partner nations
- United StatesJordanItaly
In The Last Decade
Mohammad Azab
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Ophthalmology 141
- Hematology 129
- Cancer Research 161
- Physiology 210
- Molecular Biology 514
Countries citing papers authored by Mohammad Azab
This map shows the geographic impact of Mohammad Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Azab more than expected).
Fields of papers citing papers by Mohammad Azab
This network shows the impact of papers produced by Mohammad Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Azab. The network helps show where Mohammad Azab may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Azab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 150 | |
| 2 | 2019 | 92 | |
| 3 | 2010 | 83 | |
| 4 | 2014 | 81 | |
| 5 | 2020 | 78 | |
| 6 | 2010 | 69 | |
| 7 | 2014 | 66 | |
| 8 | 2016 | 65 | |
| 9 | 2013 | 54 | |
| 10 | 2012 | 52 | |
| 11 | 2012 | 48 | |
| 12 | 2018 | 46 | |
| 13 | 2014 | 29 | |
| 14 | 2018 | 26 | |
| 15 | 2012 | 25 | |
| 16 | 2015 | 25 | |
| 17 | 2019 | 20 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2016 | 19 |
About Mohammad Azab
Mohammad Azab is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Physiology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (18 papers), Acute Myeloid Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (7 papers), RNA modifications and cancer (6 papers), Smoking Behavior and Cessation (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and School Health and Nursing Education (3 papers). The work is most often cited by research in Ophthalmology (141 citations), Hematology (129 citations), Cancer Research (161 citations), Physiology (210 citations) and Molecular Biology (514 citations). Mohammad Azab has collaborated with scholars based in United States, Jordan and Italy. Frequent co-authors include Karem H. Alzoubi, Omar F. Khabour, Pietro Taverna, Thomas Eissenberg, May F. Sadiq, Gavin Choy, Aram Oganesian, Brian A. Primack, Zaheer‐Ud‐Din Babar and Faris El‐Dahiyat. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Blood, Clinical Cancer Research and Nicotine & Tobacco Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.